Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

15.68

-0.20 (-1.26%)

At close: Jul 24, 2026, 4:00 PM EDT

15.88

+0.20 (1.28%)

Pre-market: Jul 27, 2026, 4:01 AM EDT

Sarepta Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-	-713.41	235.24	-535.98	-703.49	-418.78
Depreciation & Amortization	45.14	44.52	17.29	17.04	41.86	38.02
Stock-Based Compensation	37.97	50	37.72	182.51	233.02	113.94
Other Adjustments	-46.59	203.53	184.52	518.13	146.23	-78.19
Change in Receivables	264.55	203.76	-201.66	-185.7	-61.64	-51.65
Changes in Inventories	-193.49	-301.09	-395.17	-147.71	-50.78	-83.77
Changes in Accounts Payable	-210.47	104.27	110.65	-50.14	147.57	23.3
Changes in Accrued Expenses	-60.03	-	-	-	-	-
Changes in Unearned Revenue	-117.47	72.05	-32.16	-86.83	-89.24	-89.24
Changes in Other Operating Activities	-31.52	-0.94	-198.26	-10.71	15	103.2
Operating Cash Flow	-311.89	-205.48	-205.79	-500.99	-325.35	-443.17
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-60.4	-101.97	-136.96	-76.11	-30.82	-38.49
Purchases of Intangible Assets	-6.64	-7.88	-10	-11.24	-1.43	-2.31
Proceeds from Sale of Intangible Assets	-	-	-	102	-	102
Purchases of Investments	-174.63	-290.48	-1,104	-2,045	-1,938	-31.79
Proceeds from Sale of Investments	119.91	295.87	2,176	1,868	923.22	466
Investing Cash Flow	-121.76	69.64	755.56	-165.8	-1,047	495.41

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Short-Term Debt Issued	250	-	-	-	-	-
Short-Term Debt Repaid	-250	-	-	-	-	-
Long-Term Debt Issued	-	-	-	-	1,127	-
Long-Term Debt Repaid	-	-158.42	-	-0.07	-797.87	-
Net Long-Term Debt Issued (Repaid)	-	-158.42	-	-0.07	329.53	-
Issuance of Common Stock	3.26	38.7	79.53	51.25	30.04	569.33
Repurchase of Common Stock	-	-25.01	-	-	-	-7.77
Net Common Stock Issued (Repurchased)	3.26	13.69	79.53	51.25	30.04	561.57
Other Financing Activities	-0.96	-23.62	45.35	73.76	-127.07	-
Financing Cash Flow	-180.57	-168.34	124.81	125	232.51	561.57

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	221.13	-304.18	674.58	-541.79	-1,140	613.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-372.29	-307.45	-342.74	-577.1	-356.17	-481.66
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-17.04%	-13.99%	-18.02%	-46.42%	-38.17%	-68.62%
Free Cash Flow Per Share	-3.43	-3.07	-3.18	-6.25	-4.07	-5.93
Levered Free Cash Flow	-563.17	-1,055	-399.37	-890.5	-340.37	-465.77
Unlevered Free Cash Flow	-737.15	-894.1	-437.88	-630.46	-513.12	-506.51

SEC Filings: 10-K · 10-Q